europe cold plasma equipment Market

Europe, the cold plasma equipment market, is anticipated to reach US$ 72.57 Mn in 2027 from US$ 23.73 Mn in 2019. The market is projected to grow with a CAGR of 15.1% from 2020-2027.

The cold plasma equipment market is growing primarily due to the increasing use of cold plasma in medical treatment, increasing hospital-acquired infections (HAI), and others in the European region that are boosting the market over the years. Restraining factors, such as adverse effects of cold plasma, and lack of reimbursement, are likely to damage the growth of the market in the coming years. On the other hand, growing R&D expenditure for growth in the healthcare market is expected to have a positive impact on the growth of the European cold plasma equipment market in the coming years.

Cold plasma equipment is also called non-thermal plasma and used in a wide range of applications in various industries, including medical and biomedical sectors. It is a powerful tool that is used to provide antimicrobial treatment for wounds and injuries. The cold plasma equipment technology offers non-thermal therapy of cancer, dentistry, and others.

Cold plasma is proved very useful in biomedicine. Cold plasma is mostly used in many medical treatments such as cancer, dermatology, wound healing, atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, inflammation, scar treatment, and disinfection. Cold plasma has the ability to kill bacteria including the drug-resistant bacteria to avoid further infection which helps in treating helps in chronic wounds. By accelerating the process of wound healing and also prevents further complications and related other discomforts. Though there are many other treatments for wound healing, but it is expected that cold plasma therapy is one of the most effective way. Plasma sources which are used in plasma medicine are typically "low temperature" plasma sources widely operated at atmospheric pressure. Certainly, low temperature refers to temperatures similar to room temperature, usually slightly above. Increasing in cases of diabetes, wound and other inflammation is growing the market

Diabetes affects many parts of the body, especially feet. Diabetic foot ulcers are the forms of sores that develop on the feet, and they can develop even from seemingly minor injuries to the feet. Diabetic foot ulcers are a common cause of amputation due to diabetes. According to WHO/Europe, there are about 60 million people with diabetes in the European Region or approximately 10.3% of men and 9.6% of women aged 25 years and over. The prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet, and physical inactivity. Due to a rise in the use of cold plasma, in various kinds of treatment, it is likely to increase the cold plasma equipment market.

In 2019, the atmospheric cold plasma equipment accounted for the largest market share in the European cold plasma equipment market. Atmospheric cold plasmas, also called non-thermal plasmas, have attracted more considerable attention for its unique advantage in a new specialized field, plasma medicine. Atmospheric cold plasma gives the possibly highest plasma density. It is a unique, non-thermal glow discharge plasma operating system at atmospheric pressure. Atmospheric cold plasma, however, can also be used for the treatment of viable tissues and thus has become a focus of medical research over the past years. Other than therapeutic applications, CAP is also used for surface modification and biological decontamination. A different type of atmospheric cold plasma devices has been developed and tested for medical research purposes. In sequence, these can be divided into direct discharge (DBD: dielectric barrier discharge) and indirect discharge. Atmospheric pressure plasma jet) devices. The atmospheric cold plasma is have become a new innovative way for so many medical applications, such as disinfection, cancer treatment, root canal treatment, wound healing, and other medical applications. The atmospheric cold plasma equipment segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological development in healthcare.

In 2019, the wound healing segment held the most significant market share of the cold plasma equipment market by the application. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the patients suffering from chronic, non-healing wounds. The segment is also anticipated to witness growth at a significant rate during the forecast period.

Some of the significant primary and secondary sources for cold plasma equipment included in the report are World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC).